Although few studies of Pfetin in ovarian cancer exist, a genome-wide mutation screen identified a mutation in KCTD12 in one patient with high-grade serous ovarian cancer, suggesting its possible involvement in disease progression. This evidence concerns the gene KCTD12 and ovarian carcinoma.